Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Differential phosphorylation, desensitization, and internalization of α1A-adrenoceptors activated by norepinephrine and oxymetazoline.

Akinaga J, Lima V, Kiguti LR, Hebeler-Barbosa F, Alcántara-Hernández R, García-Sáinz JA, Pupo AS.

Mol Pharmacol. 2013 Apr;83(4):870-81. doi: 10.1124/mol.112.082313. Epub 2013 Jan 30.

3.

Comparison of human alpha1-adrenoceptor subtype coupling to protein kinase C activation and related signalling pathways.

Taguchi K, Yang M, Goepel M, Michel MC.

Naunyn Schmiedebergs Arch Pharmacol. 1998 Feb;357(2):100-10.

PMID:
9521482
4.

Bulk is a determinant of oxymetazoline affinity for the alpha1A-adrenergic receptor.

McCune D, Gaivin R, Rorabaugh B, Perez D.

Receptors Channels. 2004;10(3-4):109-16.

PMID:
15512845
6.

Carvedilol selectively inhibits oscillatory intracellular calcium changes evoked by human alpha1D- and alpha1B-adrenergic receptors.

Koshimizu TA, Tsujimoto G, Hirasawa A, Kitagawa Y, Tanoue A.

Cardiovasc Res. 2004 Sep 1;63(4):662-72.

PMID:
15306222
7.

The three α1-adrenoceptor subtypes show different spatio-temporal mechanisms of internalization and ERK1/2 phosphorylation.

Perez-Aso M, Segura V, Montó F, Barettino D, Noguera MA, Milligan G, D'Ocon P.

Biochim Biophys Acta. 2013 Oct;1833(10):2322-33. doi: 10.1016/j.bbamcr.2013.06.013. Epub 2013 Jun 21.

8.

Noradrenaline, oxymetazoline and phorbol myristate acetate induce distinct functional actions and phosphorylation patterns of α1A-adrenergic receptors.

Alcántara-Hernández R, Hernández-Méndez A, Romero-Ávila MT, Alfonzo-Méndez MA, Pupo AS, García-Sáinz JA.

Biochim Biophys Acta. 2017 Dec;1864(12):2378-2388. doi: 10.1016/j.bbamcr.2017.09.002. Epub 2017 Sep 6.

PMID:
28888989
9.

Pharmacological characterization of alpha-adrenoceptors that mediate contraction in splenic artery strips from the pig.

Barbieri A, Santagostino-Barbone MG, Zonta F, Lucchelli A.

Naunyn Schmiedebergs Arch Pharmacol. 1998 Jun;357(6):654-61.

PMID:
9686942
10.

Identification of the alpha1L-adrenoceptor in rat cerebral cortex and possible relationship between alpha1L- and alpha1A-adrenoceptors.

Morishima S, Suzuki F, Yoshiki H, Md Anisuzzaman AS, Sathi ZS, Tanaka T, Muramatsu I.

Br J Pharmacol. 2008 Apr;153(7):1485-94. doi: 10.1038/sj.bjp.0707679. Epub 2008 Jan 28.

11.

Alpha1-adrenoceptor subtypes and two receptor systems in vascular tissues.

Muramatsu I, Murata S, Isaka M, Piao HL, Zhu J, Suzuki F, Miyamoto S, Oshita M, Watanabe Y, Taniguchi T.

Life Sci. 1998;62(17-18):1461-5.

PMID:
9585119
12.

Differences in the cellular localization and agonist-mediated internalization properties of the alpha(1)-adrenoceptor subtypes.

Chalothorn D, McCune DF, Edelmann SE, García-Cazarín ML, Tsujimoto G, Piascik MT.

Mol Pharmacol. 2002 May;61(5):1008-16.

13.

Correlation between mRNA levels and functional role of alpha1-adrenoceptor subtypes in arteries: evidence of alpha1L as a functional isoform of the alpha1A-adrenoceptor.

Martí D, Miquel R, Ziani K, Gisbert R, Ivorra MD, Anselmi E, Moreno L, Villagrasa V, Barettino D, D'Ocon P.

Am J Physiol Heart Circ Physiol. 2005 Nov;289(5):H1923-32. Epub 2005 Jun 10.

14.
15.

Internalization and distribution of three alpha1-adrenoceptor subtypes in HEK293A cells before and after agonist stimulation.

Wang SY, Song Y, Xu M, He QH, Han QD, Zhang YY.

Acta Pharmacol Sin. 2007 Mar;28(3):359-66.

16.
17.

Alpha1A- and alpha1B-adrenoceptors are the major subtypes in human saphenous vein.

Yan M, Sun J, Bird PI, Liu DL, Grigg M, Lim YL.

Life Sci. 2001 Jan 26;68(10):1191-8.

PMID:
11228103
18.

Different internalization properties of the alpha1a- and alpha1b-adrenergic receptor subtypes: the potential role of receptor interaction with beta-arrestins and AP50.

Stanasila L, Abuin L, Dey J, Cotecchia S.

Mol Pharmacol. 2008 Sep;74(3):562-73. doi: 10.1124/mol.107.043422. Epub 2008 Jun 3.

19.

Antiparkinsonian agent piribedil displays antagonist properties at native, rat, and cloned, human alpha(2)-adrenoceptors: cellular and functional characterization.

Millan MJ, Cussac D, Milligan G, Carr C, Audinot V, Gobert A, Lejeune F, Rivet JM, Brocco M, Duqueyroix D, Nicolas JP, Boutin JA, Newman-Tancredi A.

J Pharmacol Exp Ther. 2001 Jun;297(3):876-87.

20.

Supplemental Content

Support Center